PreprintCited by 8Protein Structure and DynamicsMonoclonal and Polyclonal Antibodies Researchvaccines and immunoinformatics approaches

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Evaluation of Alphafold modeling for elucidation of nanobody-peptide epitope interactions

Open access

Preprint — published as 10.1016/j.jbc.2025.110268 · Paper page

Abstract

Models of Ab-antigen complexes can be used to understand interaction mechanisms and for improving affinity. This study evaluates the use of the protein structure prediction algorithm AlphaFold (AF) for exploration of interactions between peptide epitope tags and the smallest functional antibody fragments, nanobodies (Nbs). Although past studies of AF for modeling antibody-target (antigen) interactions suggested modest algorithm performance, those were primarily focused on Ab-protein interactions, while the performance and utility of AF for Nb-peptide interactions, which are generally less complex due to smaller antigens, smaller binding domains, and fewer chains, is less clear. In this study we evaluated the performance of AF for predicting the structures of Nbs bound to experimentally validated, linear, short peptide epitopes (Nb-tag pairs). We expanded the pool of experimental data available for comparison through crystallization and structural determination of a previously reported Nb-tag complex (Nb 127 ). Models of Nb-tag pair structures generated from AF were variable with respect to consistency with experimental data, with good performance in just over half (4 out of 6) of cases. Even among Nb-tag pairs successfully modeled in isolation, efforts to translate modeling to more complex contexts failed, suggesting an underappreciated role of the size and complexity of inputs in AF modeling success. Finally, the model of a Nb-tag pair with minimal previous characterization was used to guide the design of a peptide-electrophile conjugate that undergoes covalent crosslinking with Nb upon binding. These findings highlight the utility of minimized antibody and antigen structures to maximize insights from AF modeling.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1101/2025.03.14.643405

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 56

  1. 10.1093/nar/28.1.235 · DOI · Paper page
  2. 10.1093/nar/gkv1276 · DOI
  3. 10.3389/fbinf.2023.1120370 · DOI
  4. 10.1038/s41596-021-00628-9 · DOI
  5. 10.1038/s41467-022-28865-w · DOI · Paper page
  6. 10.1002/pro.4379 · DOI · Paper page
  7. 10.1002/pro.4865 · DOI · Paper page
  8. 10.1038/s41598-023-42090-5 · DOI
  9. 10.1038/s41586-024-07487-w · DOI · Paper page
  10. 10.1002/pro.5127 · DOI
  11. 10.1016/j.it.2014.04.005 · DOI
  12. 10.1016/j.csbj.2023.11.056 · DOI
  13. 10.1038/363446a0 · DOI · Paper page
  14. 10.1074/jbc.REV120.012960 · DOI
  15. 10.1146/annurev-immunol-042617-053327 · DOI
  16. 10.1038/nprot.2014.039 · DOI
  17. 10.1039/d1cb00023c · DOI
  18. 10.1038/s41467-020-15884-8 · DOI
  19. 10.1038/s41467-024-49068-5 · DOI
  20. 10.1124/molpharm.123.000797 · DOI
  21. 10.1002/pro.4866 · DOI · Paper page
  22. 10.1016/j.tibtech.2019.03.016 · DOI
  23. 10.1016/j.molimm.2019.08.008 · DOI
  24. 10.1021/acschembio.2c00407 · DOI · Paper page
  25. 10.1038/srep19211 · DOI
  26. 10.1038/s41467-018-03191-2 · DOI
  27. 10.1038/s41467-019-12301-7 · DOI
  28. 10.1016/j.cell.2019.05.001 · DOI
  29. 10.1038/s41598-020-71091-x · DOI
  30. 10.3390/antib8020038 · DOI
  31. 10.7554/eLife.74326 · DOI
  32. 10.1021/acs.bioconjchem.2c00334 · DOI
  33. 10.1038/s41592-022-01488-1 · DOI · Paper page
  34. 10.1002/prot.25870 · DOI
  35. 10.1093/bioinformatics/btaa026 · DOI
  36. 10.1021/acschembio.9b00560 · DOI
  37. 10.1002/cpz1.628 · DOI
  38. 10.1039/c5sc00190k · DOI
  39. 10.1002/anie.202213362 · DOI · Paper page
  40. 10.48550/ARXIV.2412.15970 · DOI
  41. 10.1021/acs.jcim.4c01877 · DOI · Paper page
  42. 10.1124/mol.114.094821 · DOI
  43. 10.1073/pnas.2216697120 · DOI · Paper page
  44. 10.1038/s41467-021-27838-9 · DOI · Paper page
  45. 10.1021/acs.jcim.3c00378 · DOI
  46. 10.1101/2022.07.23.501214 · DOI
  47. 10.1021/acs.jcim.3c01835 · DOI
  48. 10.1101/2024.04.19.590298 · DOI
  49. 10.1002/prot.26802 · DOI
  50. 10.1002/prot.26820 · DOI · Paper page
  51. 10.1002/prot.26801 · DOI
  52. 10.1126/science.adn6354 · DOI
  53. 10.1371/journal.pone.0161879 · DOI · Paper page
  54. 10.1016/S0076-6879(97)76066-X · DOI · Paper page
  55. 10.1107/S2059798319011471 · DOI · Paper page
  56. 10.1107/S0907444910007493 · DOI · Paper page

Metadata

Authors
Sachdev, S., Roy, S., Saha, S., Zhao, G., Kumariya, R., Creemer, B. A., Yin, R., Pierce, B. G., Bewley, C. A., & Cheloha, R. W.
Affiliations
  • National Institutes of Health (US)
  • Institute for Bioscience and Biotechnology Research (US)
Corresponding author
Cheloha, Ross W.
Venue
Journal of Biological Chemistry
Publisher
openRxiv
Published
2025-03-16
Volume
301
Issue
7
Pages
110268-110268
ISSN
0021-9258 (ISSN-L)
OpenAlex
W4410558146
Cited by
8
References
1
Citations by year
2026: 5 · 2025: 3
FWCI
2.39
Type
journal article
Language
en
Open access
Locations
  • Journal of Biological Chemistry (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, public-domain)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • PubMed Central (publishedVersion, public-domain)
  • Europe PMC (PubMed Central) (submittedVersion, public-domain)
Funders
  • National Institutes of Health (1ziadk075184-01)
  • National Institute of General Medical Sciences (GM144083, R35GM144083)
  • National Institute of Diabetes and Digestive and Kidney Diseases (1ZIADK075184, ZIADK032103, ZIADK075157)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
  • Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
Keywords
AlphaFold, nanobodies, peptide epitopes, epitope tags, antigen-antibody reaction, protein structure prediction, crystallization, structure determination, covalent cross-linking, binding affinity
MeSH terms
Algorithms, Antigen-Antibody Complex, Epitopes, Humans, Models, Molecular, Peptides, Protein Binding, Single-Domain Antibodies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review